CONCLUSION the effect of ramipril therapy on hypertension patients with hemodialysis is significance.
结论雷米普利对治疗血液透析患者高血压有效。
Results TIB in ramipril group was lower than in control group after 6 months, with no statistical difference(P>0.05).
结果治疗组TIB在出院后6个月低于对照组，但无统计学差异（P >0 .0 5 ）。
OBJECTIVE To evaluate the bioequivalence of domestic ramipril capsule and imported ramipril tablet in the healthy volunteers.
目的评价国产雷米普利胶囊与已上市的雷米普利片的人体生物等效性。
Conclusion Combined low dose of Valsartan and Ramipril increases NO levels in essential organs and inhibits remodeling of hypertensive myocardium.
结论小剂量联合应用缬沙坦和雷米普利提升重要脏器的NO值并抑制高血压心肌重塑。
We compared the ACE inhibitor ramipril, the ARB telmisartan, and the combination of the two drugs in patients with vascular disease or high-risk diabetes.
我们比较了血管紧张素转换酶抑制剂雷米普利、血管紧张素受体拮抗剂替米沙坦以及两药联合对有血管性疾病或高位糖尿病患者的作用。
Results levamlodipine group and ramipril group all can effectively reduce the blood pressure, levamlodipine's adverse reaction rate obviously lower than ramipril.
结果：左旋氨氯地平组和雷米普利组均能有效降低血压，左旋氨氯地平的不良反应发生率明显低于雷米普利。
Objective To study the antihypertensive efficacy and effect of combined therapy with Telmisartan and Ramipril on cardiac function of the patients with hypertension.
目的探讨替米沙坦和雷米普利单用或联合用药的降压作用及对心脏功能的影响。
Objective To observe the delayed protective effects of ramipril on myocardial ischemic-reperfusion injury in isolated rat hearts and explore the possible mechanisms.
目的探讨雷米普利预适应对大鼠离体心脏缺血-再灌注损伤的延迟性保护作用及机制。
The second part of the study looking at ramipril found the drug produced no delay in progression to diabetes, even though it reduced the subject's blood-sugar levels to normal.
该研究的第二部分关注雷米普利，研究发现尽管雷米普利可以将受试者的血糖降至正常水平，但它并不能延缓进展为糖尿病。
Objective To evaluate effect of Ramipril and Carvedilol on blood pressure, left ventricular weight, myocardial hypertrophy and left ventricular diastolic function, as well as their relations.
目的评价雷米普利、卡维地洛对高血压病左室肥厚患者的血压、左室质量、心肌肥厚消退程度及左室舒张功能的影响。
Conclusion it is similar that the effect of levamlodipine and ramipril in treating hypertension treatment effect, but levamlodipine with slight adverse reactions was ideal antihypertensive drugs.
结论：左旋氨氯地平和雷米普利在治疗高血压方面有相似的疗效，前者不良反应更轻微，是较理想的抗高血压新药。
Conclusion it is similar that the effect of levamlodipine and ramipril in treating hypertension treatment effect, but levamlodipine with slight adverse reactions was ideal antihypertensive drugs.
结论：左旋氨氯地平和雷米普利在治疗高血压方面有相似的疗效，前者不良反应更轻微，是较理想的抗高血压新药。
应用推荐